Health News Archive - May 01, 2010
A Norway study has revealed women with a healthy weight that remain active have a much better chance to guard themselves against the painful syndrome known as fibromyalgia.
PARSIPPANY, N.J., May 1 /PRNewswire/ -- Results of a new study found that the investigational triple combination therapy of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) demonstrated significantly greater mean reductions at week 12 in blood pressure (37.1/21.8 mm Hg versus 27.5 to 30.0/15.1-18.0 mm Hg LS Mean Reductions, P< 0.0001), as compared to corresponding dual combination therapy (dual components).(1) The study, presented at the American Society of Hypertension (ASH) annual meeting in New York, also found that at week 12, a significantly greater percentage of patients treated with the investigational triple combination therapy (OM/AML/HCTZ 40/10/25 mg) reached blood pressure goal (<140/90 mm Hg or <130/80 mm Hg for patients with diabetes, chronic renal disease, or chronic cardiovascular disease), as compared to corresponding dual components (64.3 percent versus 34.9 to 46.6 percent; P<0.0001, all comparisons).(1) The triple th
Norwegian researchers say that pregnant women are three times more likely to suffer from severe morning sickness if their mothers did.
Research presented at Experimental Biology 2010 evaluates dietary protein needs and the role of protein in weight loss and muscle maintenance.
Testing for the presence of specific cancer protein 'fingerprints' in the blood of lung cancer patients may be a useful means of identifying a subgroup whose tumors are more likely to shrink when treated with the drug erlotinib, especially when other testing methods are unavailable.
SILVER SPRING, Md., May 1 /PRNewswire-USNewswire/ -- Working in consultation with the United States Food and Drug Administration (FDA), McNeil Consumer Healthcare is implementing a voluntary recall of infant and children's liquid products due to manufacturing deficiencies which may affect quality, purity or potency.
Products may contain high levels of lead SILVER SPRING, Md., May 1 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration is advising consumers not to purchase nor consume Vita Breath, a dietary supplement manufactured by American Herbal Lab Inc.
MENOMONEE FALLS, Wis., May 1 /PRNewswire-FirstCall/ -- Kohl's Corporation (NYSE: KSS) today gathered more than 1,100 associates, family and friends together at the American Cancer Society's Making Strides Against Breast Cancer walk held in downtown Milwaukee.